The LabChip GX represents a low price entry system targeted at genomics applications, while the GXII combines both genomics and protein research applications. The LabChip GX series of instruments will be marketed by Caliper and is designed to provide scientists novel benefits including extended walk away time, higher throughput and economical plate processing ability.
The new LabChip GX instrument is said to be designed expressly for the needs of genomics researchers for the analysis of RNA integrity for better RT-PCR and microarray gene expression data, DNA fragment analysis for sequencing applications and genotyping transgenic mice, and numerous other applications that require accurate size, concentration, or purity analysis of nucleic acid samples.
The LabChip GXII system, which is a complete functional replacement of the LabChip 90, reportedly provides consistent and precise analysis of both protein and nucleic acid samples.
Rick Bunch, microfluidics product manager at Caliper Life Sciences, said: “The LabChip GX and GXII provide high quality, accurate, and reproducible data that enable researchers to accelerate their discovery efforts, while saving time and money.”